PATENT CLAIM ANALYSIS

Application Number: 16023313
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["514", "653000"]

Abstract:
The present invention is directed to epinephrine spray formulations. The present invention is further directed to methods of treating anaphylaxis by administering epinephrine spray formulations to subjects in need of such treatments.

Claim (Index 15):
An epinephrine spray formulation comprising:\n from about 0.1% w/w to about 15% w/w epinephrine or a salt thereof; and from about 1% to about 80% w/w water, wherein administration to a human of 6 milligrams of epinephrine or a salt thereof in the formulation provides a plasma concentration of more than 100 picograms per milliliter in less than 5 minutes following administration.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 94.0
- Lexical Diversity: 1.54545
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15488712', '15876553', '15601331', '15246343', '14923630']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7696071699731014
- 35 USC 102 Novelty (BERT): 0.5451742470632003
- Combined Prediction Score: 0.7471638776821113
- Mean Citation Score: 293.91530200000005
- Max Citation Score: 411.79935
- Similarity Product: 286.7554376005053

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test